Dietary Interventions for Inflammatory Bowel Disease
(AID-IBD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different diets can help individuals with inflammatory bowel disease (IBD), such as ulcerative colitis or Crohn's disease. It examines adherence to eating plans like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet, and their effects on IBD symptoms. The goal is to identify diets that improve daily life for those with IBD. Individuals diagnosed with ulcerative colitis or Crohn's disease who are open to trying a new diet might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to explore dietary changes that could enhance quality of life for those with IBD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on dietary changes for people with inflammatory bowel disease.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the diets tested for inflammatory bowel disease (IBD) are generally safe.
For the intermittent fasting method, studies suggest it can reduce gut inflammation and improve immune function. Although fasting might not change some inflammation markers, it has been linked to improvements in colitis, which is inflammation of the colon's inner lining, in certain cases.
The low FODMAP diet limits certain hard-to-digest carbohydrates and is considered safe for people with IBD. Research indicates it can ease gut symptoms without affecting the disease's inflammation levels.
The Mediterranean diet, rich in fruits, vegetables, and healthy fats, is linked to reduced gut inflammation and improved quality of life. Studies suggest it may help manage IBD with few side effects.
Overall, these diets are well-tolerated and may help manage IBD symptoms with minimal risks.12345Why are researchers excited about this trial?
Researchers are excited about these dietary interventions for inflammatory bowel disease (IBD) because they offer a fresh approach compared to the standard treatments, which often rely on medications like anti-inflammatory drugs, immune system suppressors, and biologics. Unlike these traditional options, the intermittent fasting protocol may help reduce inflammation by giving the digestive system a break, potentially resetting immune responses naturally. The Low FODMAP Diet aims to alleviate symptoms by reducing certain carbohydrates that are hard to digest, which can decrease gut irritation. Meanwhile, the Mediterranean Diet is rich in anti-inflammatory foods like fruits, vegetables, and healthy fats, which might improve gut health and reduce flare-ups. These dietary approaches are non-pharmacological, focusing on the root causes of inflammation and digestion issues in a way that many current medical treatments do not.
What evidence suggests that this trial's dietary interventions could be effective for IBD?
This trial will compare the effects of different dietary interventions on inflammatory bowel disease (IBD). Participants will be assigned to one of the following treatment arms: Intermittent Fasting, Low FODMAP Diet, or Mediterranean Diet.
Research shows that intermittent fasting can reduce intestinal inflammation, which may benefit people with IBD. Studies have found that this eating pattern can make the intestines less "leaky" and lower overall inflammation. Evidence suggests that while the Low FODMAP diet does not alter the disease itself, it helps alleviate gut symptoms like bloating and stomach pain for many individuals. Lastly, the Mediterranean diet has been found to improve quality of life and reduce inflammation in IBD patients. It positively affects gut health and is linked to better disease management and symptom relief.12456Are You a Good Fit for This Trial?
This trial is for individuals with IBD, including Ulcerative Colitis and Crohn's Disease. Participants should be interested in testing how different diets may impact their condition.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow assigned dietary interventions: intermittent fasting, Mediterranean diet, or Low FODMAP diet
Follow-up
Participants are monitored for adherence and perceived benefits of dietary interventions
What Are the Treatments Tested in This Trial?
Interventions
- Intermittent Fasting Intervention
- Low FODMAP Diet Intervention
- Mediterranean Diet Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor